Athira Pharma to Participate in Sidoti December Small Cap Investor Conference
29 Novembre 2023 - 1:00PM
Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage
biopharmaceutical company focused on developing small molecules to
restore neuronal health and slow neurodegeneration, today announced
that Company management will participate in the Sidoti December
Small Cap Conference, taking place virtually from December 6-7,
2023. Details are as follows:
Sidoti December Small Cap ConferenceFormat:
Company PresentationDate and Time: Wednesday, December 6, 2023,
from 12:15 pm - 12:45 pm EST Location: Virtual
A live webcast of the presentation can be accessed from the
Investors section of the Athira website at
https://investors.athira.com/news-and-events/events-and-presentations-investor.
An archived replay will be available for at least 30 days following
the event.
Athira Pharma will also host virtual one-on-one meetings with
investors on Wednesday, December 6 and Thursday, December 7. To
register for the conference and schedule a one-on-one meeting,
please visithttps://sidoti.com/events.
About Athira Pharma, Inc.Athira Pharma, Inc.,
headquartered in the Seattle, Washington area, is a late
clinical-stage biopharmaceutical company focused on developing
small molecules to restore neuronal health and slow
neurodegeneration. Athira aims to alter the course of neurological
disease by advancing its pipeline of therapeutic candidates
targeting the HGF neurotrophic system for Alzheimer’s and
Parkinson’s disease, Dementia with Lewy bodies, and amyotrophic
lateral sclerosis. For more information, visit www.athira.com.
You can also follow Athira on Facebook, LinkedIn and
@athirapharma on X, formerly known
as Twitter, and Instagram.
Investor & Media Contact:
Julie RathbunAthira
PharmaJulie.rathbun@athira.com206-769-9219
Grafico Azioni Athira Pharma (NASDAQ:ATHA)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Athira Pharma (NASDAQ:ATHA)
Storico
Da Set 2023 a Set 2024